IPO Synopsis

Sai Parenteral's Ltd

Registered Office: No.39 5th Flr Lavanya Arcade-,Jayabheri Enclave Gachibowli, Rangareddy - 500032, Telangana, India. Phone : +91 79979 91301   Fax: Email : cs@saiparenterals.com Website :https://www.saiparenterals.com

Initial public offer of up to 10428288 equity shares of face value of Rs. 5 each ("Equity Shares") of Sai Parenteral's Limited ("Company" or "Issuer") for cash at a price of Rs. 392 per equity share (Including a Share Premium of Rs. 387 Per Equity Share) ("Offer Price") aggregating up to Rs. 408.79 Crore comprising a fresh issue of up to 7270408 equity shares of face value of Rs. 5 each aggregating up to Rs. 285 Crore by the company ("Fresh Issue") and an offer for sale of up to 3,157,880 equity shares of face value of Rs. 5 each aggregating up to Rs. 123.79 Crore ("Offered Shares") by investor selling shareholders (such sale, the "Offer For Sale", and together with the fresh issue, the"Offer"). The offer shall constitute [*]% of the post-offer paid up equity share capital of the company. Price Band: Rs. 372 to Rs. 392 per equity share of face value of Rs. 5 each. The floor price 74.40 times the face value of the equity shares and the cap price is 78.40 times the face value of the equity shares. Bids can be made for a minimum of 38 equity shares of face value of Rs. 5 each and in multiples of 38 equity shares of face value of Rs. 5 each thereafter. Issue Opens On Closes On 24-Mar-26 27-Mar-26 Money Payable On Application Allotment 372.00 0.00 Minimum Application for shares in Nos : 38 Further Multiples of : 38 Cr Lead Managers to the Issue Project Cost (.Cr) 0.00 Arihant Capital Markets Limited Project Financed through Current Offer (.Cr) 402.47   Post Issue Equity Share Capital (.Cr) 23.67 Issue Price () 372.00

Projects

Capacity expansion and upgradation of manufacturing facilities Establishment of a new R&D Centre Repayment / prepayment of certain outstanding borrowings Working capital requirements Investment in wholly owned subsidiary, Sai Parenterals Pte Limited (Singapore), in relation to the proposed acquisition of Noumed Pharmaceuticals Pty Limited (Australia) General corporate purposes

Promoted By

Anil Kumar Karusala

Vijitha Gorrepati

Karusala Aruna

Listing At

BSE

NSE

Registrar to the Issue

No Data Available